Ionic-network dysregulation in the brain: Mechanisms, diseases, and therapeutic strategies

Siyi Han; Enduo Feng; Lize Xiong

doi:10.59717/j.xinn-tine.2026.100015

The Innovation Neurology > 2026 Vol. 1 > No. 1 > 100015

Next Article Previous Article

REVIEW Open Access

Cite PDF

Ionic-network dysregulation in the brain: Mechanisms, diseases, and therapeutic strategies

1.
Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Department of Anesthesiology and Perioperative Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai 200434, China

More Information

Corresponding authors: edfeng@tongji.edu.cn (E.F.); mzkxlz@126.com; lizexiong@tongji.edu.cn (L.X.)
Received Date: July 14, 2026

Accepted Date: September 07, 2026

Published Online: September 09, 2026

The Innovation Neurology 1(1), https://doi.org/10.59717/j.xinn-tine.2026.100015 | Cite this article

GRAPHICAL ABSTRACT

GRAPHICAL ABSTRACT

DownLoad: Full size image

PUBLIC SUMMARY

PUBLIC SUMMARY
1. Ion imbalance is a key molecular event in many neurological disorders.
  
  Altered Ca²⁺, Fe^2+/3+, Cu^+/2+, Zn²⁺, Na⁺, K⁺, Cl^-, and Mg²⁺ disrupt brain function.
  
  Shared ionic mechanisms link neurodegeneration, stroke, epilepsy and perioperative cognitive disorders.
  
  Artificial intelligence may help decode multidimensional ion networks in brain diseases.
  
  Existing therapies target parts of ionic network, but ionomics-guided strategies remain emerging frontiers.

ABSTRACT

ABSTRACT

Ionic homeostasis is a fundamental organizing principle of brain function, supporting electrical signaling, metabolic coupling, cellular communication, and neurovascular stability. Ionic-network dysregulation has emerged as an important mechanism of neurological diseases. Herein, we review the physiological architecture of brain ionic homeostasis and its dynamic organization across spatial and temporal scales. We then discuss the involvement of ionic network dysregulation in pathological cascades, including excitability imbalance, mitochondrial injury, redox stress, metal-dependent cell death, protein misfolding, neuroinflammation and barrier dysfunction and their involvement in representative neurological diseases. Furthermore, we discuss the potential role of multimodal chemical analysis and artificial intelligence in decoding ionic characteristics in neurological diseases. Finally, we review established and experimental therapies targeting ion channels, redox pathways, metal dyshomeostasis and chloride transport. This review provides an integrated framework for understanding ionic-network dysregulation as both a driver of neurological disease and a promising target for precision diagnosis, risk stratification, and mechanism-guided intervention.

FullText(HTML)

REFERENCES

[1]	Nowak, L., Bregestovski, P., Ascher, P., et al. (1984). Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307:462−465. DOI:10.1038/307462a0 View in Article CrossRef Google Scholar
[2]	Hodgkin, A.L., Huxley, A.F. (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 117:500−544. DOI:10.1113/jphysiol.1952.sp004764 View in Article CrossRef Google Scholar
[3]	Clapham, D.E. (2007). Calcium signaling. Cell 131:1047−1058. DOI:10.1016/j.cell.2007.11.028 View in Article CrossRef Google Scholar
[4]	Kawahara, M., Kato-Negishi, M., Tanaka, K.-I. (2023). Dietary Trace Elements and the Pathogenesis of Neurodegenerative Diseases. Nutrients 15:2067. DOI:10.3390/nu15092067 View in Article CrossRef Google Scholar
[5]	Abbott, N.J., Pizzo, M.E., Preston, J.E., et al. (2018). The role of brain barriers in fluid movement in the CNS: is there a ‘glymphatic’ system. Acta. Neuropathol. 135:387−407. DOI:10.1007/s00401-018-1812-4 View in Article CrossRef Google Scholar
[6]	Calvo-Rodriguez, M., Hou, S.S., Snyder, A.C., et al. (2020). Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease. Nat. Commun. 11:2146. DOI:10.1038/s41467-020-16074-2 View in Article CrossRef Google Scholar
[7]	Liu, W., Xue, Y., Cao, C., et al. (2026). Copper Homeostasis and Cuproptosis in Neurological Disorders. DDDT 20:1−32. DOI:10.2147/DDDT.S580005 View in Article CrossRef Google Scholar
[8]	Benarroch, E. (2023). What Are the Functions of Zinc in the Nervous System. Neurology 101:714−720. DOI:10.1212/WNL.0000000000207912 View in Article CrossRef Google Scholar
[9]	Hare, D.J., New, E.J., Jonge, M.D. de, et al. (2015). Imaging metals in biology: balancing sensitivity, selectivity and spatial resolution. Chem. Soc. Rev. 44:5941−5958. DOI:10.1039/c5cs00055f View in Article CrossRef Google Scholar
[10]	Grover, K., Koblova, A., Pezacki, A.T., et al. (2024). Small-Molecule Fluorescent Probes for Binding- and Activity-Based Sensing of Redox-Active Biological Metals. Chem Rev 124:5846−5929. DOI:10.1021/acs.chemrev.3c00819 View in Article CrossRef Google Scholar
[11]	Fang, T., Chen, W., Cheng, Y., et al. (2022). LA-ICP-MS bioimaging demonstrated disturbance of metal ions in the brain of Parkinson’s disease model mouse undergoing manganese-enhanced MRI. Anal. Bioanal. Chem. 414:5561−5571. DOI:10.1007/s00216-022-03994-9 View in Article CrossRef Google Scholar
[12]	Kaila, K., Price, T.J., Payne, J.A., et al. (2014). Cation-chloride cotransporters in neuronal development, plasticity and disease. Nat. Rev. Neurosci. 15:637−654. DOI:10.1038/nrn3819 View in Article CrossRef Google Scholar
[13]	Garza-Lombó, C., Posadas, Y., Quintanar, L., et al. (2018). Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress. Antioxid. Redox Signal. 28:1669−1703. DOI:10.1089/ars.2017.7272 View in Article CrossRef Google Scholar
[14]	Belosludtsev, K.N., Dubinin, M.V., Belosludtseva, N.V. (2025). Ca2+-Dependent Mitochondrial Permeability Transition Pore: Structure, Properties, and Role in Cellular Pathophysiology. Biochem. Mosc. 90:1789−1810. DOI:10.1134/S0006297925602369 View in Article CrossRef Google Scholar
[15]	Cheli, V.T., Correale, J., Paez, P.M., et al. (2020). Iron Metabolism in Oligodendrocytes and Astrocytes, Implications for Myelination and Remyelination. ASN Neuro. 12:1759091420962681 DOI:10.1177/1759091420962681. View in Article Google Scholar
[16]	Gale, J., Aizenman, E. (2024). The physiological and pathophysiological roles of copper in the nervous system. Eur J Neurosci 60:3505−3543. DOI:10.1111/ejn.16370 View in Article CrossRef Google Scholar
[17]	Giorgi, C., Marchi, S., Pinton, P. (2018). The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell. Biol. 19:713−730. DOI:10.1038/s41580-018-0052-8 View in Article CrossRef Google Scholar
[18]	Boyman, L., Karbowski, M., Lederer, W.J. (2020). Regulation of Mitochondrial ATP Production: Ca2+ Signaling and Quality Control. Trends. Mol. Med. 26:21−39. DOI:10.1016/j.molmed.2019.10.007 View in Article CrossRef Google Scholar
[19]	Markovinovic, A., Greig, J., Martín-Guerrero, S.M., et al. (2022). Endoplasmic reticulum-mitochondria signaling in neurons and neurodegenerative diseases. J. Cell Sci. 135:jcs248534. DOI:10.1242/jcs.248534 View in Article CrossRef Google Scholar
[20]	Park, S.J., Lee, S.B., Suh, Y., et al. (2017). DISC1 Modulates Neuronal Stress Responses by Gate-Keeping ER-Mitochondria Ca2+ Transfer through the MAM. Cell Rep. 21:2748−2759. DOI:10.1016/j.celrep.2017.11.043 View in Article CrossRef Google Scholar
[21]	Peng, W., Wong, Y.C., Krainc, D. (2020). Mitochondria-lysosome contacts regulate mitochondrial Ca²⁺ dynamics via lysosomal TRPML1. Proc. Natl. Acad. Sci. U.S.A. 117:19266−19275. DOI:10.1073/pnas.2003236117 View in Article CrossRef Google Scholar
[22]	Lénárt, N., Cserép, C., Császár, E., et al. (2024). Microglia–neuron–vascular interactions in ischemia. Glia 72:833−856. DOI:10.1002/glia.24487 View in Article CrossRef Google Scholar
[23]	Górska, A., Markiewicz-Gospodarek, A., Markiewicz, R., et al. (2023). Distribution of Iron, Copper, Zinc and Cadmium in Glia, Their Influence on Glial Cells and Relationship with Neurodegenerative Diseases. Brain Sciences 13:911. DOI:10.3390/brainsci13060911 View in Article CrossRef Google Scholar
[24]	Catterall, W.A. (2023). Voltage gated sodium and calcium channels: Discovery, structure, function, and Pharmacology. Channels 17:2281714. DOI:10.1080/19336950.2023.2281714 View in Article CrossRef Google Scholar
[25]	Chen, L., Shen, Q., Liu, Y., et al. (2025). Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases. Sig. Transduct. Target. Ther. 10:31. DOI:10.1038/s41392-024-02071-0 View in Article CrossRef Google Scholar
[26]	Verkhratsky, A., Hansen, L.M.B., Staehr, C., et al. (2026). The astrocytic engine: Na+,K+-ATPase at the nexus of brain function and malfunction. Am. J. Physiol. Cell Physiol 330:C238−C251. DOI:10.1152/ajpcell.00814.2025 View in Article CrossRef Google Scholar
[27]	Verkhratsky, A., Untiet, V., Rose, C.R. (2020). Ionic signalling in astroglia beyond calcium. J. Physiol. 598:1655−1670. DOI:10.1113/JP277478 View in Article CrossRef Google Scholar
[28]	Murphy-Royal, C., Ching, S., Papouin, T. (2023). A conceptual framework for astrocyte function. Nat. Neurosci. 26:1848−1856. DOI:10.1038/s41593-023-01448-8 View in Article CrossRef Google Scholar
[29]	Tang, M., Fleming, E., Gu, J., et al. (2026). Trace Elements Dyshomeostasis and Toxic Metals Neurotoxicity in Neurodegenerative Diseases. Biol. Trace. Elem. Res. 204:7264–7299 DOI:10.1007/s12011-026-05187-2. View in Article CrossRef Google Scholar
[30]	Djukic, B., Casper, K.B., Philpot, B.D., et al. (2007). Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. J. Neurosci. 27:11354–11365 DOI:10.1523/JNEUROSCI.0723-07.2007. View in Article Google Scholar
[31]	Surmeier, D.J., Obeso, J.A., Halliday, G.M. (2017). Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 18:101−113. DOI:10.1038/nrn.2016.178 View in Article CrossRef Google Scholar
[32]	Segarra, M., Aburto, M.R., Acker-Palmer, A. (2021). Blood–Brain Barrier Dynamics to Maintain Brain Homeostasis. Trends Neurosci. 44:393−405. DOI:10.1016/j.tins.2020.12.002 View in Article CrossRef Google Scholar
[33]	Institoris, A., Vandal, M., Peringod, G., et al. (2022). Astrocytes amplify neurovascular coupling to sustained activation of neocortex in awake mice. Nat. Commun. 13:7872. DOI:10.1038/s41467-022-35383-2 View in Article CrossRef Google Scholar
[34]	Liu, R., Collier, J.M., Abdul-Rahman, N.-H., et al. (2024). Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer’s Disease and Vascular Dementia. Aging Dis. 15:1748−1770. DOI:10.14336/AD.2023.1201 View in Article CrossRef Google Scholar
[35]	Huang, X., Qi, J., Su, Y., et al. (2024). Endothelial DR6 in blood-brain barrier malfunction in Alzheimer’s disease. Cell Death Dis. 15:258. DOI:10.1038/s41419-024-06639-0 View in Article CrossRef Google Scholar
[36]	Korte, N., Barkaway, A., Wells, J., et al. (2024). Inhibiting Ca2+ channels in Alzheimer’s disease model mice relaxes pericytes, improves cerebral blood flow and reduces immune cell stalling and hypoxia. Nat. Neurosci. 27:2086−2100. DOI:10.1038/s41593-024-01753-w View in Article CrossRef Google Scholar
[37]	Cressman, J.R., Ullah, G., Ziburkus, J., et al. (2009). The influence of sodium and potassium dynamics on excitability, seizures, and the stability of persistent states: I. Single neuron dynamics. J. Comput. Neurosci. 26:159−170. DOI:10.1007/s10827-008-0132-4 View in Article CrossRef Google Scholar
[38]	Hadi, F., Mortaja, M., Hadi, Z. (2024). Calcium (Ca2+) hemostasis, mitochondria, autophagy, and mitophagy contribute to Alzheimer’s disease as early moderators. Cell Biochem. Funct. 42:e4085. DOI:10.1002/cbf.4085 View in Article CrossRef Google Scholar
[39]	Jin, S., Tian, Y., Hacker, J., et al. (2024). Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in the SOD1G93A ALS model. Sci. Adv. 10:eadq3350. DOI:10.1126/sciadv.adq3350 View in Article CrossRef Google Scholar
[40]	Wu, W., Gong, X., Qin, Z., et al. (2025). Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases—an update. Acta. Pharmacol. Sin. 46:3129−3142. DOI:10.1038/s41401-025-01576-w View in Article CrossRef Google Scholar
[41]	Zhu, M., Sun, H., Cao, L., et al. (2022). Role of Na+/K+-ATPase in ischemic stroke: in-depth perspectives from physiology to pharmacology. J. Mol. Med. (Berl) 100:395−410. DOI:10.1007/s00109-021-02143-6 View in Article CrossRef Google Scholar
[42]	Zhao, J., Sun, J., Zheng, Y., et al. (2022). Activated astrocytes attenuate neocortical seizures in rodent models through driving Na+-K+-ATPase. Nat. Commun. 13:7136. DOI:10.1038/s41467-022-34662-2 View in Article CrossRef Google Scholar
[43]	Côme, E., Marques, X., Poncer, J.C., et al. (2020). KCC2 membrane diffusion tunes neuronal chloride homeostasis. Neuropharmacology 169:107571. DOI:10.1016/j.neuropharm.2019.03.014 View in Article CrossRef Google Scholar
[44]	Adrichem, J.J. van, Loo, R.J. van der, Ambrosini Defendi, R., et al. (2025). Progressive remote memory decline coincides with parvalbumin interneuron hyperexcitability and enhanced inhibition of cortical engram cells in a mouse model of Alzheimer’s disease. eLife 14:RP106866. DOI:10.7554/eLife.106866 View in Article CrossRef Google Scholar
[45]	Best, F.V., Hartings, J.A., Ngwenya, L.B. (2025). Repetitive cortical spreading depolarizations are prolonged early after experimental traumatic brain injury. Exp. Neurol. 385:115120. DOI:10.1016/j.expneurol.2024.115120 View in Article CrossRef Google Scholar
[46]	Zhang, W., Xiong, B.R., Zhang, L.Q., et al. (2020). Disruption of the GABAergic system contributes to the development of perioperative neurocognitive disorders after anesthesia and surgery in aged mice. CNS Neurosci. Ther. 26:913−924. DOI:10.1111/cns.13388 View in Article CrossRef Google Scholar
[47]	Calvo-Rodriguez, M., Kharitonova, E.K., Snyder, A.C., et al. (2024). Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer’s disease. Mol. Neurodegeneration 19:6. DOI:10.1186/s13024-024-00702-2 View in Article CrossRef Google Scholar
[48]	Feofilaktova, T., Kushnireva, L., Segal, M., et al. (2025). Calcium signaling in postsynaptic mitochondria: mechanisms, dynamics, and role in ATP production. Front. Mol. Neurosci. 18:1621070. DOI:10.3389/fnmol.2025.1621070. View in Article Google Scholar
[49]	Jomova, K., Alomar, S.Y., Valko, R., et al. (2025). The role of redox-active iron, copper, manganese, and redox-inactive zinc in toxicity, oxidative stress, and human diseases. EXCLI J 24:880−954. DOI:10.17179/excli2025-8449 View in Article CrossRef Google Scholar
[50]	Ji, S.G., Weiss, J.H. (2018). Zn2+-induced disruption of neuronal mitochondrial function: synergism with Ca2+, critical dependence upon cytosolic Zn2+ buffering, and contributions to neuronal injury. Exp. Neurol. 302:181−195. DOI:10.1016/j.expneurol.2018.01.012 View in Article CrossRef Google Scholar
[51]	Ru, Q., Li, Y., Chen, L., et al. (2024). Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduction Targeted Ther. 9:271. DOI:10.1038/s41392-024-01969-z View in Article CrossRef Google Scholar
[52]	Feinsod, H., Stockwell, B.R. (2026). Fundamental mechanism of ferroptosis: Three unanswered questions. Ferroptosis Oxid Stress 2:202512. DOI:10.70401/fos.2026.0015 View in Article CrossRef Google Scholar
[53]	Bersuker, K., Hendricks, J.M., Li, Z., et al. (2019). The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575:688−692. DOI:10.1038/s41586-019-1705-2 View in Article CrossRef Google Scholar
[54]	Mao, C., Liu, X., Zhang, Y., et al. (2021). DHODH-mediated ferroptosis defense is a targetable vulnerability in cancer. Nature 593:586−590. DOI:10.1038/s41586-021-03539-7 View in Article CrossRef Google Scholar
[55]	Li, Q., Han, X., Lan, X., et al. (2017). Inhibition of neuronal ferroptosis protects hemorrhagic brain. JCI Insight 2:e90777. DOI:10.1172/jci.insight.90777. View in Article Google Scholar
[56]	Levi, S., Ripamonti, M., Moro, A.S., et al. (2024). Iron imbalance in neurodegeneration. Mol. Psychiatry 29:1139−1152. DOI:10.1038/s41380-023-02399-z View in Article CrossRef Google Scholar
[57]	Miao, M., Han, Y., Wang, Y., et al. (2024). Dysregulation of iron homeostasis and ferroptosis in sevoflurane and isoflurane associated perioperative neurocognitive disorders. CNS Neurosci. Ther. 30:e14553. DOI:10.1111/cns.14553 View in Article CrossRef Google Scholar
[58]	Chen, L., Min, J., Wang, F. (2022). Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther 7:378. DOI:10.1038/s41392-022-01229-y View in Article CrossRef Google Scholar
[59]	Tsvetkov, P., Coy, S., Petrova, B., et al. (2022). Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375:1254−1261. DOI:10.1126/science.abf0529 View in Article CrossRef Google Scholar
[60]	Li, Q., Li, D., Li, Y., et al. (2025). Investigating cuproptosis and mitochondrial dysfunction in brain cells: uncovering novel mechanisms and biomarkers for Parkinson’s disease. Metab Brain Dis 40:144. DOI:10.1007/s11011-025-01574-1 View in Article CrossRef Google Scholar
[61]	Hansson, O. (2021). Biomarkers for neurodegenerative diseases. Nat. Med. 27:954−963. DOI:10.1038/s41591-021-01382-x View in Article CrossRef Google Scholar
[62]	Juárez-Romero, G.U., Sun, X., Gerez, J.A., et al. (2026). Structural insights into copper and zinc binding to tau protein and the impact of metal binding on amyloid aggregation. Chem. Sci. 17:7277−7296. DOI:10.1039/d5sc08604c View in Article CrossRef Google Scholar
[63]	Hosseinpour Mashkani, S.M., Bishop, D.P., Raoufi-Rad, N., et al. (2023). Distribution of Copper, Iron, and Zinc in the Retina, Hippocampus, and Cortex of the Transgenic APP/PS1 Mouse Model of Alzheimer’s Disease. Cells 12:1144. DOI:10.3390/cells12081144 View in Article CrossRef Google Scholar
[64]	Mao, Y., Zhang, L., Zhang, C., et al. (2025). The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights. J. Trace Elem. Med. Biol. 90:127692. DOI:10.1016/j.jtemb.2025.127692 View in Article CrossRef Google Scholar
[65]	Fani, G., Mannini, B., Vecchi, G., et al. (2021). Aβ Oligomers Dysregulate Calcium Homeostasis by Mechanosensitive Activation of AMPA and NMDA Receptors. ACS Chem. Neurosci. 12:766−781. DOI:10.1021/acschemneuro.0c00811 View in Article CrossRef Google Scholar
[66]	Cosson, T., Faller, P., Pountney, D.L. (2025). Toxic Tango in Parkinson’s Disease: A dance between αSyn and iron import, export and speciation. Neurochem. Int. 190:106053. DOI:10.1016/j.neuint.2025.106053 View in Article CrossRef Google Scholar
[67]	Castillo-Casaña, Y., Arias, C., Coria, R. (2025). Tau–Mitochondria Interactions in Neurodegeneration: Mechanisms and Therapeutic Potential. Cell Mol Neurobiol 46:3. DOI:10.1007/s10571-025-01634-1 View in Article CrossRef Google Scholar
[68]	Gonzalez-Garcia, M., Fusco, G., De Simone, A. (2023). Metal interactions of α-synuclein probed by NMR amide-proton exchange. Front. Chem. 11:1167766 DOI:10.3389/fchem.2023.1167766 View in Article Google Scholar
[69]	Eren-Koçak, E., Dalkara, T. (2021). Ion Channel Dysfunction and Neuroinflammation in Migraine and Depression. Front. Pharmacol. 12:777607. DOI:10.3389/fphar.2021.777607 View in Article CrossRef Google Scholar
[70]	Zimmermann, S., Mathew, A., Bondareva, O., et al. (2024). Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain. Kidney Int. 106:1101−1116. DOI:10.1016/j.kint.2024.06.028 View in Article CrossRef Google Scholar
[71]	Fomina, A.F., Nguyen, H.M., Wulff, H. (2021). Kv1.3 inhibition attenuates neuroinflammation through disruption of microglial calcium signaling. Channels 15:67–78 DOI:10.1080/19336950.2020.1853943. View in Article Google Scholar
[72]	Sarkar, S., Nguyen, H.M., Malovic, E., et al. (2020). Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease. J. Clin. Invest. 130:4195–4212 DOI:10.1172/JCI136174. View in Article Google Scholar
[73]	Lee, G.-S., Subramanian, N., Kim, A.I., et al. (2012). The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492:123−127. DOI:10.1038/nature11588 View in Article CrossRef Google Scholar
[74]	Galic, M.A., Riazi, K., Pittman, Q.J. (2012). Cytokines and brain excitability. Front. Neuroendocrinol. 33:116−125. DOI:10.1016/j.yfrne.2011.12.002 View in Article CrossRef Google Scholar
[75]	Kim, H.Y., Kim, S., Akaydin, A.N., et al. (2026). The rise of astrocytes: are they guardians or troublemakers of the brain disorder. Exp. Mol. Med. 58:301−318. DOI:10.1038/s12276-025-01627-6 View in Article CrossRef Google Scholar
[76]	Yauger, Y.J., Bermudez, S., Moritz, K.E., et al. (2019). Iron accentuated reactive oxygen species release by NADPH oxidase in activated microglia contributes to oxidative stress in vitro. J. Neuroinflammation 16:41. DOI:10.1186/s12974-019-1430-7 View in Article CrossRef Google Scholar
[77]	Hou, Y., Dan, X., Babbar, M., et al. (2019). Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 15:565−581. DOI:10.1038/s41582-019-0244-7 View in Article CrossRef Google Scholar
[78]	Mao, L., Wang, L., Huang, Z., et al. (2025). Perioperative neurocognitive disorders: Advances in molecular mechanisms and bioactive molecules. Ageing Res. Rev. 112:102885. DOI:10.1016/j.arr.2025.102885 View in Article CrossRef Google Scholar
[79]	Badenes, R., Romero-Garcia, N., Marshall, T.J. (2026). The perioperative brain: navigating neurological risks in non-neurosurgical patients. Intensive Care Med:1–4 DOI:10.1007/s00134-026-08299-4. View in Article Google Scholar
[80]	Wu, D., Chen, Q., Chen, X., et al. (2023). The blood–brain barrier: Structure, regulation and drug delivery. Signal Transduct Target Ther. 8:217. DOI:10.1038/s41392-023-01481-w View in Article CrossRef Google Scholar
[81]	Andjelkovic, A.V., Situ, M., Citalan-Madrid, A.F., et al. (2023). Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments. Stroke 54:661−672. DOI:10.1161/STROKEAHA.122.040578 View in Article CrossRef Google Scholar
[82]	Zille, M., Karuppagounder, S.S., Chen, Y., et al. (2017). Neuronal Death After Hemorrhagic Stroke In Vitro and In Vivo Shares Features of Ferroptosis and Necroptosis. Stroke 48:1033−1043. DOI:10.1161/STROKEAHA.116.015609 View in Article CrossRef Google Scholar
[83]	Bayır, H., Anthonymuthu, T.S., Tyurina, Y.Y., et al. (2020). Achieving Life through Death: Redox Biology of Lipid Peroxidation in Ferroptosis. Cell Chem. Biol. 27:387−408. DOI:10.1016/j.chembiol.2020.03.014 View in Article CrossRef Google Scholar
[84]	Gruenbaum, B.F., Zlotnik, A., Dubilet, M., et al. (2026). Role of Blood–Brain Barrier Permeability in Delirium Pathophysiology and Treatment. Anesthesiology 144:203. DOI:10.1097/ALN.0000000000005722 View in Article CrossRef Google Scholar
[85]	Uchida, Y., Kan, H., Sakurai, K., et al. (2020). Iron leakage owing to blood-brain barrier disruption in small vessel disease CADASIL. Neurology 95:e1188−e1198. DOI:10.1212/WNL.0000000000010148 View in Article CrossRef Google Scholar
[86]	Hu, S., Fei, Y., Jin, C., et al. (2024). Ginsenoside Rd enhances blood-brain barrier integrity after cerebral ischemia/reperfusion by alleviating endothelial cells ferroptosis via activation of NRG1/ErbB4-mediated PI3K/Akt/mTOR signaling pathway. Neuropharmacology 251:109929. DOI:10.1016/j.neuropharm.2024.109929 View in Article CrossRef Google Scholar
[87]	Aron, L., Ngian, Z.K., Qiu, C., et al. (2025). Lithium deficiency and the onset of Alzheimer’s disease. Nature 645:712−721. DOI:10.1038/s41586-025-09335-x View in Article CrossRef Google Scholar
[88]	Deng, P., Silva, M., Yang, N., et al. (2025). Artemisinin inhibits neuronal ferroptosis in Alzheimer’s disease models by targeting KEAP1. Acta Pharmacol. Sin. 46:326−337. DOI:10.1038/s41401-024-01378-6 View in Article CrossRef Google Scholar
[89]	Guan, X., Lancione, M., Ayton, S., et al. (2024). Neuroimaging of Parkinson’s disease by quantitative susceptibility mapping. Neuroimage 289:120547. DOI:10.1016/j.neuroimage.2024.120547 View in Article CrossRef Google Scholar
[90]	López-Aguirre, M., Balzano, T., Monje, M.H.G., et al. (2025). Nigrostriatal iron accumulation in the progression of Parkinson’s disease. npj Parkinsons Dis. 11:72. DOI:10.1038/s41531-025-00911-6 View in Article CrossRef Google Scholar
[91]	Ryan, S.K., Zelic, M., Han, Y., et al. (2023). Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. Nat. Neurosci. 26:12−26. DOI:10.1038/s41593-022-01221-3 View in Article CrossRef Google Scholar
[92]	Peikon, I., Andrews, N.C. (2026). Isn’t it ironic? Functional iron deficiency at the core of Parkinson’s disease pathobiology. J Clin Invest 136 :e202244. DOI:10.1172/JCI202244. View in Article Google Scholar
[93]	Yao, Z., Jiao, Q., Du, X., et al. (2024). Ferroptosis in Parkinson’s disease -- The iron-related degenerative disease. Ageing Res. Rev. 101:102477 DOI:10.1016/j.arr.2024.102477 View in Article Google Scholar
[94]	Sirabella, R., Valsecchi, V., Anzilotti, S., et al. (2018). Ionic Homeostasis Maintenance in ALS: Focus on New Therapeutic Targets. Front. Neurosci. 12:510. DOI:10.3389/fnins.2018.00510. View in Article Google Scholar
[95]	LoRusso, E., Hickman, J.J., Guo, X. (2019). Ion channel dysfunction and altered motoneuron excitability in ALS. Neurol. Disord. Epilepsy J. 3:124 View in Article Google Scholar
[96]	Wang, H., Sun, Q., Du, R., et al. (2026). Serum Trace Elements and Their Associations with Disease Progression and Survival in Sporadic Amyotrophic Lateral Sclerosis: Insights from a Chinese Cohort. Biomed. Environ. Sci. 39:183−191. DOI:10.3967/bes2025.094 View in Article CrossRef Google Scholar
[97]	Benatar, M., Robertson, J., Andersen, P.M. (2025). Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention. The Lancet Neurology 24:77−86. DOI:10.1016/S1474-4422(24)00479-4 View in Article CrossRef Google Scholar
[98]	Witte, M.E., Schumacher, A.-M., Mahler, C.F., et al. (2019). Calcium Influx through Plasma-Membrane Nanoruptures Drives Axon Degeneration in a Model of Multiple Sclerosis. Neuron 101:615−624.e5. DOI:10.1016/j.neuron.2018.12.023 View in Article CrossRef Google Scholar
[99]	Hu, H.-J., Song, M. (2017). Disrupted Ionic Homeostasis in Ischemic Stroke and New Therapeutic Targets. J. Stroke Cerebrovasc. Dis. 26:2706−2719. DOI:10.1016/j.jstrokecerebrovasdis.2017.09.011 View in Article CrossRef Google Scholar
[100]	Lindquist, B.E. (2024). Spreading depolarizations pose critical energy challenges in acute brain injury. J. Neurochem. 168:868−887. DOI:10.1111/jnc.15966 View in Article CrossRef Google Scholar
[101]	Schoknecht, K., Baeza-Lehnert, F., Hirrlinger, J., et al. (2025). Spreading depolarizations exhaust neuronal ATP in a model of cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 122:e2415358122. DOI:10.1073/pnas.2415358122 View in Article CrossRef Google Scholar
[102]	Cao, W., Xu, Y. (2025). Nimodipine Blocks Histone-Induced Calcium Overload to Protect Neurons after Traumatic Brain Injury. Antioxid. Redox Sign. 43:869−885. DOI:10.1177/15230864251376030 View in Article CrossRef Google Scholar
[103]	Zhang, X., Zhang, Y., Su, Q., et al. (2024). Ion Channel Dysregulation Following Intracerebral Hemorrhage. Neurosci. Bull. 40:401−414. DOI:10.1007/s12264-023-01118-6 View in Article CrossRef Google Scholar
[104]	Liu, J., Pang, S.-Y., Zhou, S.-Y., et al. (2024). Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1/Nrf2/HO-1 pathway. Redox Biol. 76:103342. DOI:10.1016/j.redox.2024.103342 View in Article CrossRef Google Scholar
[105]	Khanna, A., Kahle, K.T., Walcott, B.P., et al. (2014). Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema. Transl. Stroke Res. 5:3−16. DOI:10.1007/s12975-013-0307-9 View in Article CrossRef Google Scholar
[106]	Zhang, Y., Jiang, M., Wei, M., et al. (2025). MgSO4 as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca2+ regulation of neurovascular units. Theranostics 15:1896−1913. DOI:10.7150/thno.104879 View in Article CrossRef Google Scholar
[107]	Yang, Q., Wei, X., Deng, B., et al. (2022). Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment. Neurobiol. Dis. 170:105750. DOI:10.1016/j.nbd.2022.105750 View in Article CrossRef Google Scholar
[108]	Debanne, D., Mylonaki, K., Musella, M.L., et al. (2024). Voltage-gated ion channels in epilepsies: circuit dysfunctions and treatments. Trends Pharmacol. Sci 45:1018−1032. DOI:10.1016/j.tips.2024.09.004 View in Article CrossRef Google Scholar
[109]	Oyrer, J., Maljevic, S., Scheffer, I.E., et al. (2018). Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies. Pharmacol. Rev. 70:142−173. DOI:10.1124/pr.117.014456 View in Article CrossRef Google Scholar
[110]	McMoneagle, E., Zhou, J., Zhang, S., et al. (2024). Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment. Acta Pharmacol. Sin. 45:1−22. DOI:10.1038/s41401-023-01149-9 View in Article CrossRef Google Scholar
[111]	Çarçak, N., Onat, F., Sitnikova, E. (2023). Astrocytes as a target for therapeutic strategies in epilepsy: current insights. Front. Mol. Neurosci. 16:1183775. DOI:10.3389/fnmol.2023.1183775 View in Article CrossRef Google Scholar
[112]	Du, M., Li, J., Chen, L., et al. (2018). Astrocytic Kir4.1 channels and gap junctions account for spontaneous epileptic seizure. PLoS Comput. Biol. 14:e1005877 DOI:10.1371/journal.pcbi.1005877. View in Article Google Scholar
[113]	Tyurikova, O., Kopach, O., Zheng, K., et al. (2025). Astrocyte Kir4.1 expression level territorially controls excitatory transmission in the brain. Cell Rep. 44:115299 DOI:10.1016/j.celrep.2025.115299 View in Article Google Scholar
[114]	Chen, Z.-P., Zhao, X., Wang, S., et al. (2025). GABA-dependent microglial elimination of inhibitory synapses underlies neuronal hyperexcitability in epilepsy. Nat. Neurosci. 28:1404−1417. DOI:10.1038/s41593-025-01979-2 View in Article CrossRef Google Scholar
[115]	Ji, S.G., Weiss, J.H. (2018). Zn2+-induced disruption of neuronal mitochondrial function: synergism with Ca2+, critical dependence upon cytosolic Zn2+ buffering, and contributions to neuronal injury. Exp. Neurol. 302:181−195. DOI:10.1016/j.expneurol.2018.01.012 View in Article Google Scholar
[116]	Reiffurth, C., Berndt, N., Gonzalez Lopez, A., et al. (2023). Deep Isoflurane Anesthesia Is Associated with Alterations in Ion Homeostasis and Specific Na+/K+-ATPase Impairment in the Rat Brain. Anesthesiology 138:611−623. DOI:10.1097/ALN.0000000000004553 View in Article CrossRef Google Scholar
[117]	Mattson, M.P., Arumugam, T.V. (2018). Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Cell Metab. 27:1176−1199. DOI:10.1016/j.cmet.2018.05.011 View in Article CrossRef Google Scholar
[118]	Cong P., Chen Q., Wu Q., et al. (2025). Aging and perioperative brain health: Mechanisms, management, and future. Chin. Med. J. 138:2381. DOI:10.1097/CM9.0000000000003735 View in Article CrossRef Google Scholar
[119]	Chen, M., Yan, R., Ding, L., et al. (2023). Research Advances of Mitochondrial Dysfunction in Perioperative Neurocognitive Disorders. Neurochem. Res. 48:2983−2995. DOI:10.1007/s11064-023-03962-4 View in Article CrossRef Google Scholar
[120]	Huo, Q., Zhang, Y., Guo, J., et al. (2025). Dexmedetomidine protects against postoperative neurocognitive disorder by mitigating mitochondrial dysfunction through regulating the IP3R-GRP75-VDAC1 complex-mediated calcium transport. Immunol. Res. 73:156. DOI:10.1007/s12026-025-09705-7 View in Article CrossRef Google Scholar
[121]	Zhang, Z., Yang, W., Wang, L., et al. (2024). Unraveling the role and mechanism of mitochondria in postoperative cognitive dysfunction: a narrative review. J. Neuroinflammation 21:293. DOI:10.1186/s12974-024-03285-3 View in Article CrossRef Google Scholar
[122]	Wu, J., Yang, J.-J., Cao, Y., et al. (2020). Iron overload contributes to general anaesthesia-induced neurotoxicity and cognitive deficits. J. Neuroinflammation 17:110. DOI:10.1186/s12974-020-01777-6 View in Article CrossRef Google Scholar
[123]	Ge, X., Zuo, Y., Xie, J., et al. (2021). A new mechanism of POCD caused by sevoflurane in mice: cognitive impairment induced by cross-dysfunction of iron and glucose metabolism. Aging (Albany NY) 13:22375−22389. DOI:10.18632/aging.203544 View in Article CrossRef Google Scholar
[124]	Lin, L., Ling, X., Chen, T., et al. (2025). Inhibition of Hippocampal Neuronal Ferroptosis by Liproxstatin-1 Improves Learning and Memory Function in Aged Mice with Perioperative Neurocognitive Dysfunction. J. Inflamm. Res. 18:2991–3007. DOI:10.2147/JIR.S503784. View in Article CrossRef Google Scholar
[125]	Zhang, Y., Xu, Y., Zheng, L. (2020). Disease Ionomics: Understanding the Role of Ions in Complex Disease. Int. J. Mol. Sci. 21:8646. DOI:10.3390/ijms21228646 View in Article CrossRef Google Scholar
[126]	Ebner, B.A., Erdahl, S.A., Lundgreen, C.S., et al. (2025). Brain tissue metal concentrations and Alzheimer’s disease neuropathology in total joint arthroplasty patients versus controls. Acta Neuropathol. 149:18. DOI:10.1007/s00401-025-02856-9 View in Article CrossRef Google Scholar
[127]	Ashraf, A., Michaelides, C., Walker, T.A., et al. (2019). Regional Distributions of Iron, Copper and Zinc and Their Relationships With Glia in a Normal Aging Mouse Model. Front. Aging Neurosci. 11 DOI:10.3389/fnagi.2019.00351 View in Article Google Scholar
[128]	Pushie, M.J., Sylvain, N.J., Hou, H., et al. (2024). X-ray fluorescence mapping of brain tissue reveals the profound extent of trace element dysregulation in stroke pathophysiology. Metallomics 16:mfae054. DOI:10.1093/mtomcs/mfae054 View in Article CrossRef Google Scholar
[129]	Timoshenko, R.V., Gorelkin, P.V., Vaneev, A.N., et al. (2024). Electrochemical Nanopipette Sensor for In Vitro/In Vivo Detection of Cu2+ Ions. Anal. Chem. 96:127−136. DOI:10.1021/acs.analchem.3c03337 View in Article CrossRef Google Scholar
[130]	Gu, C., Kong, F., Liang, S., et al. (2024). In vivo dynamic tracking of cerebral chloride regulation using molecularly tailored liquid/liquid interfacial ultramicro iontronics. Sci. Adv. 10:eadr7218. DOI:10.1126/sciadv.adr7218 View in Article CrossRef Google Scholar
[131]	Guo, L., Xie, C., Miao, R., et al. (2024). DeepION: A Deep Learning-Based Low-Dimensional Representation Model of Ion Images for Mass Spectrometry Imaging. Anal. Chem. 96:3829−3836. DOI:10.1021/acs.analchem.3c05002 View in Article CrossRef Google Scholar
[132]	Dürr, S.L., Levy, A., Rothlisberger, U. (2023). Metal3D: a general deep learning framework for accurate metal ion location prediction in proteins. Nat. Commun. 14:2713. DOI:10.1038/s41467-023-37870-6 View in Article CrossRef Google Scholar
[133]	Lucas, A., Revell, A., Davis, K.A. (2024). Artificial intelligence in epilepsy — applications and pathways to the clinic. Nat. Rev. Neurol. 20:319−336. DOI:10.1038/s41582-024-00965-9 View in Article CrossRef Google Scholar
[134]	Epilepsies in children, young people and adults (2025). National Institute for Health and Care Excellence (NICE). View in Article Google Scholar
[135]	Reuben, D.B., Kremen, S., Maust, D.T. (2024). Dementia Prevention and Treatment: A Narrative Review. JAMA Intern. Med. 184:563−572. DOI:10.1001/jamainternmed.2023.8522 View in Article CrossRef Google Scholar
[136]	Hoh, B.L., Ko, N.U., Amin-Hanjani, S., et al. (2023). 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke 54:e314−e370. DOI:10.1161/STR.0000000000000436 View in Article CrossRef Google Scholar
[137]	Abe, K., Aoki, M., Tsuji, S., et al. (2017). Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 16:505−512. DOI:10.1016/S1474-4422(17)30115-1 View in Article CrossRef Google Scholar
[138]	Huang, S.-L., Shen, Y.-L., Peng, W.-Y., et al. (2024). Edaravone for patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Acta Neurol. Belg. 124:895−904. DOI:10.1007/s13760-024-02476-2 View in Article CrossRef Google Scholar
[139]	Ayton, S., Barton, D., Brew, B., et al. (2025). Deferiprone in Alzheimer Disease: A Randomized Clinical Trial. JAMA Neurol. 82:11−18. DOI:10.1001/jamaneurol.2024.3733 View in Article CrossRef Google Scholar
[140]	Devos, D., Labreuche, J., Rascol, O., et al. (2022). Trial of Deferiprone in Parkinson’s Disease. N. Engl. J. Med. 387:2045−2055. DOI:10.1056/NEJMoa2209254 View in Article CrossRef Google Scholar
[141]	Wei, C., Wang, J., Foster, L.D., et al. (2022). Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial. Stroke 53:1149−1156. DOI:10.1161/STROKEAHA.121.035421 View in Article CrossRef Google Scholar
[142]	Shi, W., Yuan, S., Cheng, G., et al. (2024). Blood brain barrier-targeted lipid nanoparticles improved the neuroprotection of Ferrostatin-1 against cerebral ischemic damage in an experimental stroke model. Exp. Neurol. 379:114849. DOI:10.1016/j.expneurol.2024.114849 View in Article CrossRef Google Scholar
[143]	Geng, Y., Qiu, L., Cheng, Y., et al. (2024). Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor. Adv. Sci. 11:2309517. DOI:10.1002/advs.202309517 View in Article CrossRef Google Scholar
[144]	Lam, P., Newland, J., Faull, R.L.M., et al. (2023). Cation-Chloride Cotransporters KCC2 and NKCC1 as Therapeutic Targets in Neurological and Neuropsychiatric Disorders. Molecules 28:1344. DOI:10.3390/molecules28031344 View in Article CrossRef Google Scholar
[145]	Soul, J.S., Bergin, A.M., Stopp, C., et al. (2021). A Pilot Randomized, Controlled, Double‐Blind Trial of Bumetanide to Treat Neonatal Seizures. Ann. Neurol. 89:327−340. DOI:10.1002/ana.25959 View in Article CrossRef Google Scholar
[146]	Boudries, R., Williams, H., Paquereau-Gaboreau, S., et al. (2024). Surface-Enhanced Raman Scattering Nanosensing and Imaging in Neuroscience. ACS Nano 18:22620–22647 DOI:10.1021/acsnano.4c05200 View in Article Google Scholar

Cited by

ABOUT THIS ARTICLE

Cite this article:

Han S., Feng E. and Xiong L. (2026). Ionic-network dysregulation in the brain: Mechanisms, diseases, and therapeutic strategies. The Innovation Neurology 1:100015. https://doi.org/10.59717/j.xinn-tine.2026.100015

Han S., Feng E. and Xiong L. (2026). Ionic-network dysregulation in the brain: Mechanisms, diseases, and therapeutic strategies. The Innovation Neurology 1:100015. https://doi.org/10.59717/j.xinn-tine.2026.100015

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF

Figures(5) Tables(1)

Article Metrics

Article views(240) PDF downloads(77)

Ionic-network dysregulation in the brain: Mechanisms, diseases, and therapeutic strategies

GRAPHICAL ABSTRACT

PUBLIC SUMMARY

ABSTRACT

REFERENCES

ABOUT THIS ARTICLE

Cite this article:

Welcome!

Share

Article Metrics

Relative Articles

Cited by

Catalog

{{newsColumn.name}}

Official Account

{{newsColumn.name}}

Stay connected

{{newsColumn.name}}

Ionic-network dysregulation in the brain: Mechanisms, diseases, and therapeutic strategies

GRAPHICAL ABSTRACT

PUBLIC SUMMARY

ABSTRACT

REFERENCES

ABOUT THIS ARTICLE

Cite this article:

Welcome!

Share

Article Metrics

Relative Articles

Cited by

Catalog

Export File

Citation

Format

Content

{{newsColumn.name}}

Official Account

{{newsColumn.name}}

Stay connected

{{newsColumn.name}}